cyclosporine has been researched along with Leukemia, Pre-B-Cell in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aui, PM; Bosco, JJ; Grigg, A; Pumar, M; Shuttleworth, P; Smart, JM; van Zelm, MC | 1 |
Arseniev, L; Bähre, O; Diedrich, H; Kadar, JG; Link, H; Poliwoda, H | 1 |
Inoue, M; Kawa, K; Nakayama, M; Okamura, T; Takeuchi, M; Yagi, K | 1 |
1 trial(s) available for cyclosporine and Leukemia, Pre-B-Cell
Article | Year |
---|---|
Transplantation of allogeneic CD34+ blood cells.
Topics: Acute Disease; Adult; Antigens, CD34; Bone Marrow; Cell Division; Cyclosporine; Erythropoietin; Female; Filgrastim; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Leukapheresis; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Platelet Transfusion; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Recombinant Proteins; T-Lymphocytes; Transplantation, Homologous | 1996 |
2 other study(ies) available for cyclosporine and Leukemia, Pre-B-Cell
Article | Year |
---|---|
Functional Antibody Responses Following Allogeneic Stem Cell Transplantation for
Topics: Adult; Agammaglobulinemia; Cyclosporine; Genetic Diseases, X-Linked; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Male; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Transplantation Conditioning; Tumor Suppressor Protein p53 | 2019 |
Mosquito allergy and Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease.
Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Culicidae; Cyclosporine; Epstein-Barr Virus Infections; Female; Hematopoietic Stem Cell Transplantation; Herpesvirus 4, Human; Humans; Hypersensitivity; Immunocompromised Host; Immunosuppressive Agents; Insect Bites and Stings; Killer Cells, Natural; Lymphoproliferative Disorders; Male; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Receptors, Antigen, T-Cell, gamma-delta; Remission Induction; Skin; T-Lymphocyte Subsets; Virus Activation | 2001 |